Using LeDock as a docking tool for computational drug design

Ni Liu, Zhibin Xu*

*Corresponding author for this work

Research output: Contribution to journalConference articlepeer-review

44 Citations (Scopus)

Abstract

Computer-Aided drug design (CADD) is an emerging tool for research and drug development process as it reduces the time taken for the process of drug development and expense. Molecular docking technology, as one of the main method, has been widely used in many fields of drug development. Based on the dopamine D3 receptor target, this paper describes the method of molecular docking using LeDock software (Windows version) in combination with the docking process of eticlopride ligand and D3 receptor. This method can predict the binding mode of ligands to proteins, including binding energy, binding sites and attractive interactions types. Four representative D3 receptor ligands, including BP897, NGB2904, FAUC365 and SB277011A, were respectively docked with D3 receptor by this method. By analyzing the docking results, we can conclude that the molecular docking method using LeDock software plays an important role in the drug design process.

Original languageEnglish
Article number012143
JournalIOP Conference Series: Earth and Environmental Science
Volume218
Issue number1
DOIs
Publication statusPublished - 25 Feb 2019
Event2018 International Conference on Civil, Architecture and Disaster Prevention, ICCADP 2018 - Hefei, China
Duration: 19 Oct 201821 Oct 2018

Fingerprint

Dive into the research topics of 'Using LeDock as a docking tool for computational drug design'. Together they form a unique fingerprint.

Cite this